Date: Tue, 10 Apr 2018 12:54:44 +0100 From: "Saket Vayeda" <saket@vipharmaevents.com> To: gnome@freebsd.org Subject: Pharma AI & IoT 2018 (Conference) Message-ID: <12332509868720232827077@Piyush>
next in thread | raw e-mail | index | archive | help
Pharma AI & IoT 2018 =93Integrating AI, IoT, Cloud & Big Data Analytics in Pharma & Healthcare=94 11th & 12th July 2018, Canary Riverside Plaza Hotel, London UK =20 Conference Information: There needs to be a fundamental shift in drug discovery and artificial Inte= lligence holds the key to bringing the pharma industry into the 21st Centur= y. From discovery and development and through the entire product lifecycle,= artificial intelligence (AI) is starting to shake up the life-sciences ind= ustry. The potential of intelligent apps (i.e., apps that are capable of le= arning from experience) is so far-reaching that it is expected that AI-enab= led drugs will be brought to market in the near future. A Silicon Valley Ba= nk analysis last month found that 44 venture-backed deals raised $2.2 billi= on between 2015 and the first half of 2017 for Dx/Tools companies that use = AI/ML as part of their underlying technology. A report from Aruba states th= at 60 percent of health care organizations across the world have started us= ing the internet of things in their facilities. Current uses include insuli= n delivery, activity trackers for cancer treatment, ingestible sensors, dep= ression-fighting apps, and more. A growing need for healthier lifestyles coupled with breakthrough technolog= ical innovation has been instrumental in boosting adoption, and the global = IoT healthcare market is expected to grow from USD32.4 Bn in 2015 to USD163= .2 Bn by 2020, a CAGR of 38.1%. One of the world=92s biggest markets for he= althcare services, the United States spends approximately 18% of its GDP on= healthcare every year. By improving adherence to prescribed therapies alon= e, the US could significantly reduce their healthcare spends. The effective= deployment of IoT-based healthcare delivery technologies could help the US= save well over USD 300 billion Our Pharma AI & IoT 2018 will provide insight into the current state of pla= y in the EU & US and stimulate debate, in a multi-stakeholder setting, on t= he vital role of techonologyy impact in the sustainability of pharma and he= althcare systems. Beyond a comprehensive outlook of key European market acc= ess policies, our speakers will outline the key recent developments in tec= hnology impact in pharma and healthcare in the EU and other international j= urisdictions. By attending this conference, you will gain a comprehensive o= utlook on the key issues surrounding latest technologies that are being ana= lysed towards the pharma and healthcare. This event will provide an importa= nt platform for stakeholders to discuss and share best practices in further= ing technology development in pharma and healthcare It gives me great pleasure in welcoming all of you to the Virtue Insight=92= s Pharma AI & IoT 2018. =20 Key Speakers: TANMAY BAKSHI, World=92s youngest Artificial Intelligence (AI) expert and a= member of IBM=92s AI team and TED speaker, IBM MARGARET McDONALD, Senior Director, Real World Data & Analytics, Patient & = Health Impact, PFIZER (USA) SHWEN GWEE, Head of Digital Strategy, Global Clinical Operations, Biogen (U= SA) ROBERT BARBERO, Cloud Customer Engineer, Google JAMES WEATHERALL, Executive Director and Head of Advanced Analytics Centre,= AstraZeneca DARREN GREEN, Director, Molecular Design UK, RD Platform Technology & Scien= ce, GSK PHILIPPE GERWILL, Industry Advisor - IoTSG (Singapore) IT Supplier Manageme= nt TOQ IT and EUX, Novartis HERVE DUMAS, Director - Patient Care Solution Lead, UCB ABHINANDAN RAGHAVAN, Data Scientist, Technology and Functional Lead (Inform= atics), Novartis PHILIP MAURER, Google Cloud Customer Engineer, Google GABOR PURMAN, Behavioural Economist, Purman Consulting (Former Associate Di= rector, Teva Pharmaceuticals) PETER RUTHERFORD, Medical Lead, Renal Orphan, Vifor Pharma EDDIE GUZDAR, Medical Affairs Physician, LEO Pharma NATHALIE LAHITTE, Digital Marketing Manager, Lundbeck SHERAZ MAJEED, Palliative Medicine Consultant, NHS SLAVA AKMAEV, Senior Vice President & Chief Analytics Officer, BERG (USA) EOIN LEYDON, Lead for Advanced Analytics in Pharma, Associate Partner, Quan= tumBlack-McKinsey FINN CATLING, ACCS Anaesthetics CT1 Doctor, University College London Hospi= tals NHS Foundation Trust JORGE ARMANET M, CEO & Co-Founder, HealthUnlocked RADOUANE OUDRHIRI, CTO, Eagle Genomics ABRAHAM JOSEPH, Founder & Editorial Director, IOT Insights PAUL MICHAEL AGAPOW, Head of Translational Bioinformatics, Data Science Ins= titute, Imperial College London PAUL HARTIGAN, CEO, PharmiWeb Solutions MARK DUMAN, Director, MD Healthcare MARIE MONTOYA, Director, M Montoya Consultancy AXEL SCHUMACHER, Co-Founder & CEO, Project Shivom RYO SAKAI, Data Visualization & Scientific Communications Lead, PharmiWeb S= olutions Key Themes Market overview and Analysis Shaping the future of AI in Pharma AI for Precision Medicine How AI technology can accelerate, cheapen and De-Risk R&D Machine learning in patient stratification, genomic analysis, population in= vestigation and real world data Exploring R&D applications in machine learning AI - Challenges exist, but opportunities beckon Scaling your business with implementation of AI AI to increase pharma innovation IoT & IIoT - The new Rx for pharma manufacturing & supply chains Cyber Security is Critical in an Age of IoT and Healthcare Hacks Big Pharma, Big Data - Big Deal=3F Yes, Really! How big data can revolutionise pharmaceutical R&D Promise and challenge of Big Data for Pharma Pharma to open up big data for clinical trials, analytics Clinical Trials innovations with big data and advanced analytics era IoT could save billions in healthcare costs across the US and Europe Differences that Internet of Things (IoT) Can Make to Healthcare How IoT is poised to transform the world of pharma Developing regulatory framework in advanced and developing markets =96 for = Today & Tomorrow Moving beyond 5 years =96 What will the technology landscape look like=3F Be part of a major networking opportunity Why Should You Sponsor: =20 Virtue Insight Conferences and events offer commercial organisations and pa= rtners a wide range of opportunities to promote their products and services= at our events during the calendar year! All of our Virtue Insight sponsors= hip opportunities are tailored to your requirements and we provide a number= of flexible packages that will meet your company=92s marketing objectives.= Sponsorship can be used in a number of ways to increase your brand and pro= duct awareness in both a highly targeted and clutter free environment. Part= nering with Virtue Insight allows you to showcase your brand and product in= a professional and independent setting, when our delegates are in a recept= ive and engaging mindset. Our experts will work with you and your team, to = create real added value to any campaign and we welcome the opportunity to d= iscuss your requirements in detail. Furthermore, Virtue Insight has a hard = earned reputation for forming strong, long standing and valuable partnershi= ps with our sponsors and we will work hard to deliver your campaign, on tim= e and on budget! =20 Benifits of Sponsorship: Access a niche, hard to reach, targeted audience within your industry secto= rs Talk to key industry specialists within business, academic and government b= odies Develops market leadership, through a role that fosters dialogue on key bus= iness issues and trends Generates prospects and sales, by bringing customers to you Provides a respected forum for your ideas on topics that affect your busine= ss Amplifies your message, by providing a setting of heightened receptiveness Provides influence, through face-to-face opportunities to engage in dialogu= e with thought and decision leaders Advantages Provides a practical, well respected avenue to market leadership Presents opportunities to form important, new business relationships Demonstrate corporate brand values to a wider audience Change or enhance Brand perceptions Drive Brand =91Consideration=92 Gain credible Brand Endorsement Showcase new Product launches Provide a cost effective and focused platform on which to engage your consu= mers Networking; Bringing together buyers and sellers in a independent and intim= ate environment Exposure to international experts; via our conferences, website, email data= base, Social Media and Newsletters Meeting your customers; they could be current, former or even potential cus= tomers. Discover what the factors influencing them are and what they think = about you and your competitors. Who Should Attend: CIOs, CEOs, CDOs, Vice Presidents, Presidents, Heads, Directors, Team Leade= rs, Evangelists and Senior Scientists from the following area: Pharmaceuticals Biotech Artificial Intelligence Data Science Machine Learning IoT Cloud Advanced Analytics Innovation Big Data Deep Learning Bioinformatics Regulatory Compliance New Product Development Process Science Portfolio Management Research & Development Business Development Business Operations Scientific Affairs Commercial Affairs Marketing Why Should You Attend: =20 Pharma AI & IoT 2018 =96 =93Integrating AI, IoT, Cloud & Big Data Analytics= in Pharma & Healthcare" Get more from the event, enjoy and make the best out of our dedicated netwo= rking drinks time, meet the leading international vendors showcasing the pr= oducts of tomorrow in the co-located exhibition. Expand your knowledge of t= he latest business models and strategies in the high-level conference. Whet= her you are on the branded or generic side, you cannot afford to miss this = opportunity to benchmark your tactics and strategies against the industry l= eaders who will be the first to traverse the pathway. Devise an immediate a= ction plan for your biosimilar prosecution and litigation strategies in lig= ht of the barriers to entry, research and development costs, and regulatory= hurdles, which are balanced against an enormous potential for increased pr= ofit margins. =20 Conference Booking Details: Super Early Bird Pricing (till 08-May-2018) : =A3600 + VAT Per Delegate Super Early Bird Pricing (till 08-May-2018) : =A31200 + VAT (3 Delegates at= price of 2) for 3 Delegates=20 You can simply email and book your conference delegate seats Conference Sponsor & Exhibition Space =96 Should you wish to Sponsor, or pu= rchase a Exhibiton Stall (Booth) or a paid Speaker Slot, you can simply ema= il your interest and queries to saket@viconferences.co.uk Registration process To register simply email the below mentioned details to saket@viconferences= .co.uk Company: Invoice Address: Numbers of Attendees: Attendee Name/Names: Job Title =20 Unable to attend: Obviously nothing compares to being there but you not need to miss out. Si= mply send the above information for getting a copy of all speakers's presen= tation slides and other materials that will come out of the conference for = Just =A3400. Please contact me if you have any ruther questions I look forward to hearing from you. Kind Regards Saket Vayeda Events Manager =20 =20 To Unsubscribe send an email with Unsubscribe in the subject line to info@v= iconferences.com
Want to link to this message? Use this URL: <https://mail-archive.FreeBSD.org/cgi/mid.cgi?12332509868720232827077>